In a similar manner, the impairment of glucose metabolism, mainly due to lower aerobic glycolysis, was linked with higher tau protein deposition in the vulnerable brain regions of pre-clinical and mildly symptomatic AD patients [81]. This evidence concerns the gene MAPT and Alzheimer disease.